MG PHARMA INC has a total of 32 patent applications. Its first patent ever was published in 1995. It filed its patents most often in China, EPO (European Patent Office) and Hong Kong. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are HOLDINGBOLAGET VID GOETEBORGS, KAEL GEMVAX CO LTD and GEMVAX & KAEL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Hong Kong | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Australia | 3 | |
#6 | Canada | 3 | |
#7 | Republic of Korea | 3 | |
#8 | United States | 3 | |
#9 | Norway | 2 | |
#10 | Finland | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Peptides | |
#5 | Special foods | |
#6 | Fodder | |
#7 | Coffee | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Kagawa Kyoichi | 28 |
#2 | Fukuhama Chizuko | 28 |
#3 | Fujino Hiroaki | 10 |
#4 | Sasakawa Yuka | 10 |
#5 | Hidasa Junnei | 9 |
#6 | Tong Chunning | 8 |
#7 | Naruse Toshihiko | 6 |
#8 | Nakamura Toyoo | 4 |
#9 | Honda Kazuhisa | 4 |
#10 | Matsutaka Hisako | 4 |
Publication | Filing date | Title |
---|---|---|
US2018360899A1 | Agent for maintaining healthy obesity | |
AU2009310912A1 | Peptide having anti-diabetic activity and use thereof | |
WO2009020189A1 | Anti-hypertensive agent | |
US2007191282A1 | Composition for suppressing re-elevation of cholesterol, and usage thereof | |
WO2006052031A1 | Protein hydrolysate with antidiabetic effect |